<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ssmu</journal-id><journal-title-group><journal-title xml:lang="ru">Бюллетень сибирской медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin of Siberian Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-0363</issn><issn pub-type="epub">1819-3684</issn><publisher><publisher-name>Siberian State Medical University, the Ministry of Healthcare of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20538/1682-0363-2018-3-5-12</article-id><article-id custom-type="elpub" pub-id-type="custom">ssmu-1278</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL PAPERS</subject></subj-group></article-categories><title-group><article-title>Влияние раково-эмбрионального антигена на продукцию цитокинов иммунокомпетентными клетками крови у больных с опухолями молочной железы</article-title><trans-title-group xml:lang="en"><trans-title>The effect of canceroembryonic antigen on cytokine production by immunocompetent blood cells in patients with breast cancer</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аутеншлюс</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Autenshlus</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Аутеншлюс Александр Исаевич - доктор биологических наук, профессор, зав. центральной научно-исследовательской лабораторией (ЦНИЛ) НГМУ; главный научный сотрудник НИИ МББ.</p><p>630091, Новосибирск, Красный пр., 52; 630117, Новосибирск, ул. Тимакова, 2/12</p></bio><bio xml:lang="en"><p>Autenshlus Alexander I. - DBSc, Professor, Head of Laboratory NSMU; Chief Researcher IMBB.</p><p>52, Krasny Av., Novosibirsk, 630091; 2/12, Timakov Str., Novosibirsk, 630117</p></bio><email xlink:type="simple">lpciip@211.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кунц</surname><given-names>Т. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kunts</surname><given-names>T. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кунц Татьяна Анатольевна - кандидат биологических наук, старший научный сотрудник, ЦНИЛ, НГМУ.</p><p>630091, Новосибирск, Красный пр., 52</p></bio><bio xml:lang="en"><p>Kunts Tatyana A. - PhD, Senior Researcher, NSMU.</p><p>52, Krasny Av., Novosibirsk, 630091</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Карпухина</surname><given-names>К. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Karpukhina</surname><given-names>K. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Карпухина Ксения Викторовна - научный сотрудник.</p><p>630117, Новосибирск, ул. Тимакова, 2/12</p></bio><bio xml:lang="en"><p>Karpukhina Ksenia V. - Researcher, IMBB.</p><p>2/12, Timakov Str., Novosibirsk, 630117</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Михайлова</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Mikhailova</surname><given-names>E. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Михайлова Елена Семеновна - научный сотрудник, ЦНИЛ, НГМУ; старший научный сотрудник, НИИ МББ.</p><p>630091, Новосибирск, Красный пр., 52; 630117, Новосибирск, ул. Тимакова, 2/12</p></bio><bio xml:lang="en"><p>Mikhailova Elena S. - Researcher, NSMU; Senior Researcher, IMBB.</p><p>52, Krasny Av., Novosibirsk, 630091; 2/12, Timakov Str., Novosibirsk, 630117</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вараксин</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Varaksin</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Вараксин Николай Анатольевич - зав. лабораторией.</p><p>630559, Новосибирская обл., р.п. Кольцово</p></bio><bio xml:lang="en"><p>Varaksin Nikolay A. - Head of Laboratory, JSC “Vector-best”, Koltsovo.</p><p>Koltsovo, Novosibirsk Region, 630559</p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Маринкин</surname><given-names>И. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Marinkin</surname><given-names>I. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Маринкин Игорь Олегович - доктор медицинских наук, профессор, зав. кафедрой, НГМУ.</p><p>630091, Новосибирск, Красный пр., 52</p></bio><bio xml:lang="en"><p>Marinkin Igor O. - DM, Professor, Head of Department, NSMU.</p><p>52, Krasny Av., Novosibirsk, 630091</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Новосибирский государственный медицинский университет (НГМУ); Научно-исследовательский институт молекулярной биологии и биофизики (НИИ МББ)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Novosibirsk State Medical University (NSMU); Institute of Molecular Biology and Biophysics (IMBB)</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Новосибирский государственный медицинский университет (НГМУ)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Novosibirsk State Medical University (NSMU)</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Научно-исследовательский институт молекулярной биологии и биофизики (НИИ МББ)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute of Molecular Biology and Biophysics (IMBB)</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ЗАО Вектор-Бест</institution><country>Россия</country></aff><aff xml:lang="en"><institution>JSC Vector-best</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>29</day><month>09</month><year>2018</year></pub-date><volume>17</volume><issue>3</issue><fpage>5</fpage><lpage>12</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Аутеншлюс А.И., Кунц Т.А., Карпухина К.В., Михайлова Е.С., Вараксин Н.А., Маринкин И.О., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Аутеншлюс А.И., Кунц Т.А., Карпухина К.В., Михайлова Е.С., Вараксин Н.А., Маринкин И.О.</copyright-holder><copyright-holder xml:lang="en">Autenshlus A.I., Kunts T.A., Karpukhina K.V., Mikhailova E.S., Varaksin N.A., Marinkin I.O.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://bulletin.ssmu.ru/jour/article/view/1278">https://bulletin.ssmu.ru/jour/article/view/1278</self-uri><abstract><p>Цель – изучение влияния раково-эмбрионального антигена (РЭА) на иммунокомпетентные клетки крови при опухолях молочной железы.</p><sec><title>Материалы и методы</title><p>Материалы и методы. Исследована периферическая кровь 67 пациентов с инвазивным протоковым раком (n = 44), фиброаденомой (n = 12) и предраковыми состояниями молочной железы (n = 11). В супернатантах клеток крови иммуноферментным анализом определяли продукцию цитокинов, индуцированную РЭА.</p></sec><sec><title>Результаты</title><p>Результаты. Обнаружено, что у больных с фиброаденомой РЭА стимулировал выработку IL-6, IL-8, IL-10, IL-1β, IL-1Ra, TNFα, G-CSF, GM-CSF и белка MCP-1 по сравнению с группами больных с инвазивным протоковым раком и предраковыми состояниями. Индексы влияния РЭА на продукцию цитокинов иммунокомпетентными клетками в этих группах были ниже, чем при фиброаденоме вследствие изначально высокой спонтанной продукции цитокинов.</p></sec><sec><title>Заключение</title><p>Заключение. Выявлена выраженная спонтанная цитокинпродуцирующая функция иммунокомпетентных клеток крови пациентов с инвазивным протоковым раком и предраковыми состояниями по сравнению с группой пациентов с фиброаденомой. Различия в индексах влияния РЭА на продукцию цитокинов у пациентов со злокачественными, доброкачественными и предраковыми состояниями могут служить основой создания методов дифференциальной диагностики опухолей молочной железы.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. Investigation of the influence of canceroembryonic antigen (CEA) on the immune cells in patients with breast tumors.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. Peripheral blood of 67 patients with invasive ductal carcinoma (n = 44), fibroadenoma (n = 12) and breast pre-cancer (n = 11). In the supernatants of the blood cells cytokine production induced by CEA was determined by ELISA.</p></sec><sec><title>Results</title><p>Results. It was found that CEA stimulated production of IL-6, IL-8, IL-10, IL-1β, IL-1Ra, TNFα, G-CSF, GM-CSF and the protein MCP-1 by blood immune cells in patients with fibroadenoma compared with groups of patients with invasive ductal carcinoma and precancerous lesions. Stimulation index of CEA on cytokine production by immunocompetent cells in patients in these groups was lower than in groups of patients with fibroadenoma due to initially high levels of spontaneous cytokine production.</p></sec><sec><title>Results</title><p>Results.  In  patients  with  fibroadenoma  CEA  was  found  to  stimulate  the  production  of  IL-6,  IL-8,  IL-10,  IL-1β,  IL-1Ra,  TNFa,  G-CSF,  GM-CSF  and  MCP-1  compared  with  groups  of  patients  with  invasive ductal carcinoma and precancerous conditions. Indexes of the influence of CEA on cytokine production by immunocompetent cells in these groups was lower than in the fibroadenoma due to initially high spontaneous production of cytokines.</p></sec><sec><title>Conclusion</title><p>Conclusion.  Evident  spontaneous  cytokine-producing  function  of  immunocompetent  blood  cells  was revealed in patients with invasive ductal carcinoma and precancerous conditions compared to patients with fibroadenoma.  The  differences  between  the  indices  of  CEA  influence  on  cytokine  production  in  patients with malignant, benign and precancerous conditions can serve as a basis for the development of methods of differential diagnosis of breast tumors.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>раково-эмбриональный антиген</kwd><kwd>цитокины</kwd><kwd>инвазивный протоковый рак</kwd><kwd>фиброаденома</kwd><kwd>предраковые состояния</kwd><kwd>молочная железа</kwd></kwd-group><kwd-group xml:lang="en"><kwd>canceroembryonic antigen</kwd><kwd>cytokines</kwd><kwd>invasive ductal carcinoma</kwd><kwd>fibroadenoma</kwd><kwd>pre-cancer</kwd><kwd>breast</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Pavlopoulou A., Scorilas A. A comprehensive phylogenetic and structural analysis of the carcinoembryonic antigen (CEA) gene family. Genome Biol. Evol. 2014; 6 (6): 1314–1326. DOI: 10.1093/gbe/evu103.</mixed-citation><mixed-citation xml:lang="en">Pavlopoulou A., Scorilas A. A comprehensive phylogenetic and structural analysis of the carcinoembryonic antigen (CEA) gene family. Genome Biol. Evol. 2014; 6 (6): 1314–1326. DOI: 10.1093/gbe/evu103.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Duffy M.J. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clinical Chemistry. 2001; 47 (4): 624–630. http://clinchem.aaccjnls.org/content/47/4/624.full</mixed-citation><mixed-citation xml:lang="en">Duffy M.J. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clinical Chemistry. 2001; 47 (4): 624–630. http://clinchem.aaccjnls.org/content/47/4/624.full</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Гатауллин И.Г., Петров С.В., Валиев А.А., Шакиров Р.К. Прогностическая модель эффективности лечения больных колоректальным раком. Поволжский онкологический вестник. 2010; 1 (1): 27–30. http://elibrary.ru/item.asp?id=23498987.</mixed-citation><mixed-citation xml:lang="en">Gataullin I.G., Petrov S.V., Valiev A.A., Shakirov R.K. Prognostic model of treatment efficacy of colorectal cancer patients. Povolzhsky onkologichesky vestnik – Oncology Bulletin of the Volga Region. 2010; 1 (1): 27–30 (in Russ.). http://elibrary.ru/item.asp?id=23498987.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Deng K., Yang L., Hu B., Wu H., Zhu H., Tang C. The prognostic significance of pretreatment serum CEA levels in gastric cancer: a meta-analysis including 14651 patients. Plos. One. 2015; 10: e124151. DOI: 10.1371/journal.pone.0124151.</mixed-citation><mixed-citation xml:lang="en">Deng K., Yang L., Hu B., Wu H., Zhu H., Tang C. The prognostic significance of pretreatment serum CEA levels in gastric cancer: a meta-analysis including 14651 patients. Plos. One. 2015; 10: e124151. DOI: 10.1371/journal.pone.0124151.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kim C.H., M.D., Lee S.Y., Kim H.R., Kim Y.J. Prognostic effect of pretreatment serum carcinoembryonicantigen level: a useful tool for prediction of distant metastasis in locally advanced rectal cancer following neoadjuvant chemoradiotherapy and total mesorectal excision. Medicine. 2015; 94 (31): 1–7. DOI: 10.1097/MD.0000000000001291.</mixed-citation><mixed-citation xml:lang="en">Kim C.H., M.D., Lee S.Y., Kim H.R., Kim Y.J. Prognostic effect of pretreatment serum carcinoembryonicantigen level: a useful tool for prediction of distant metastasis in locally advanced rectal cancer following neoadjuvant chemoradiotherapy and total mesorectal excision.  Medicine. 2015; 94 (31): 1–7. DOI: 10.1097/MD.0000000000001291.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Wang J., Wang X., Yu F., Chen J., Zhao S., Zhang D., Yu Y., Liu X., Tang H., Peng Z. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically. Int. J. Clin. Exp. Pathol. 2015; 8 (11): 14853–14863. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713601</mixed-citation><mixed-citation xml:lang="en">Wang J., Wang X., Yu F., Chen J., Zhao S., Zhang D., Yu Y., Liu X., Tang H., Peng Z. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically. Int. J. Clin. Exp. Pathol. 2015; 8 (11): 14853–14863. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713601</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Grunnet M., Sorensen J.B. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer. 2012; 76 (2): 138–143. DOI: 10.1016/j.lungcan.2011.11.012.</mixed-citation><mixed-citation xml:lang="en">Grunnet M., Sorensen J.B. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer. 2012; 76 (2): 138–143. DOI: 10.1016/j.lungcan.2011.11.012.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Wang J.Y., Lu C.Y., Chu K.S., Ma C.J., Wu D.C., Tsai H.L., Yu F.J., Hsieh J.S. Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer. Eur. Surg. Res. 2007; 39: 245–250. DOI: 10.1159/000101952.</mixed-citation><mixed-citation xml:lang="en">Wang J.Y., Lu C.Y., Chu K.S., Ma C.J., Wu D.C., Tsai H.L., Yu F.J., Hsieh J.S. Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer. Eur. Surg. Res. 2007; 39: 245–250. DOI: 10.1159/000101952.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bhatt A.N., Mathur R., Farooque A., Verma A., Dwarakanath B.S. Cancer biomarkers−current perspectives. Indian J. Med. Res. 2010; 132: 129–149. http://www.ijmr.org.in/downloadpdf.asp?issn=0971-5916;year=2010;volume=132;issue=2;spage=129;epage=149;aulast=Bhatt;type=2.</mixed-citation><mixed-citation xml:lang="en">Bhatt A.N., Mathur R., Farooque A., Verma A., Dwarakanath B.S. Cancer biomarkers−current perspectives. Indian J. Med. Res. 2010; 132: 129–149. http://www.ijmr.org.in/downloadpdf.asp?issn=0971-5916;year=2010;volume=132;issue=2;spage=129;epage=149;aulast=Bhatt;type=2.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Lee J.S., Park S., Park J.M., Cho J.H., Kim S.I., Park B.W. Elevated levels of preoperative CA 15–3 and CEA serum levels have independently poor prognostic significance in breast cancer. Ann. Oncol. 2013; 24: 1225–1231. DOI: 10.1093/annonc/mds604 PMID: 232301379.</mixed-citation><mixed-citation xml:lang="en">Lee J.S., Park S., Park J.M., Cho J.H., Kim S.I., Park B.W. Elevated levels of preoperative CA 15–3 and CEA serum levels have independently poor prognostic significance in breast cancer. Ann. Oncol. 2013; 24: 1225–1231. DOI: 10.1093/annonc/mds604 PMID: 232301379.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Pedersen A.C., Sorensen P.D., Jacobsen E.H., Madsen J.S., Brandslund I. Sensitivity of CA 15–3, CEA and serum HER2 in the early detection of recurrence of breast cancer. Clin. Chem. Lab. Med. 2013; 51 (7): 1511–1519. DOI: 10.1515/cclm-2012-0488 PMID: 23403727.</mixed-citation><mixed-citation xml:lang="en">Pedersen A.C., Sorensen P.D., Jacobsen E.H., Madsen J.S., Brandslund I. Sensitivity of CA 15–3, CEA and serum HER2 in the early detection of recurrence of breast cancer. Clin. Chem. Lab. Med. 2013; 51 (7): 1511–1519. DOI: 10.1515/cclm-2012-0488 PMID: 23403727.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Wu S.G., He Z.Y., Zhou J., Sun J.Y., Li F.Y., Lin Q., Guo L., Lin H.X. Serum levels of CEA and CA15-3 in different molecular subtypes and prognostic value in Chinese breast cancer. Breast. 2014; 23: 88–93. DOI: 10.1016/j.breast.2013.11.003 PMID: 24291374.</mixed-citation><mixed-citation xml:lang="en">Wu S.G., He Z.Y., Zhou J., Sun J.Y., Li F.Y., Lin Q., Guo L., Lin H.X. Serum levels of CEA and CA15-3 in different molecular subtypes and prognostic value in Chinese breast cancer. Breast. 2014; 23: 88–93. DOI: 10.1016/j.breast.2013.11.003 PMID: 24291374.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Wu L., Huang P., Wang F., Li D., Xie E., Zhang Y., Pan S. Relationship between serum CA19-9 and CEA levels and prognosis of pancreatic cancer. Ann. Transl. Med. 2015; 3 (21): 328–331. DOI: 10.3978/j.issn.2305-5839.2015.11.17.</mixed-citation><mixed-citation xml:lang="en">Wu L., Huang P., Wang F., Li D., Xie E., Zhang Y., Pan S. Relationship between serum CA19-9 and CEA levels and prognosis of pancreatic cancer. Ann. Transl. Med. 2015; 3 (21): 328–331. DOI: 10.3978/j.issn.2305-5839.2015.11.17.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Hashiguchi Y., Kasai M., Fukuda T., Ichimura T., Yasui T., Sumi T. Serum carcinoembryonic antigen asa tumour marker in patients with endometrial cancer. Curr. Oncol. 2016; 23 (5): e439–e442. DOI: 10.3747/co.23.3153.</mixed-citation><mixed-citation xml:lang="en">Hashiguchi Y., Kasai M., Fukuda T., Ichimura T., Yasui T., Sumi T. Serum carcinoembryonic antigen asa tumour marker in patients with endometrial cancer. Curr. Oncol. 2016; 23 (5): e439–e442. DOI: 10.3747/co.23.3153.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Barak V., Meirovitz A., Leibovici V., Rachmut J., Peretz T., Eliashar R., Gross M. The diagnostic and prognosticn value of tumor markers (CEA, SCC, CYFRA 21-1, TPS) in head and neck cancer patients. Anticancer Res. 2015; 35 (10): 5519–5524. http://ar.iiarjournals.org/content/35/10/5519.long.</mixed-citation><mixed-citation xml:lang="en">Barak V., Meirovitz A., Leibovici V., Rachmut J., Peretz T., Eliashar R., Gross M. The diagnostic and prognosticn value of tumor markers (CEA, SCC, CYFRA 21-1, TPS) in head and neck cancer patients. Anticancer Res. 2015; 35 (10): 5519–5524. http://ar.iiarjournals.org/content/35/10/5519.long.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Saito H., Noji T., Okamura K., Tsuchikawa T., Shichinohe T., Hirano S. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma. Surgery. 2016; 159 (3): 842–851. DOI: 10.1016/j.surg.2015.10.027.</mixed-citation><mixed-citation xml:lang="en">Saito H., Noji T., Okamura K., Tsuchikawa T., Shichinohe T.,  Hirano S. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma. Surgery. 2016; 159 (3): 842–851. DOI: 10.1016/j.surg.2015.10.027.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Liska V., Treska V., Skalicky T., Fichtl J., Bruha J., Vycital O., Topolcan O. , Palek R., Rosendorf J., Polivka J., Holubec L. Evaluation of tumor markers and their impact on prognosis in gallbladder, bile duct and cholangiocellular carcinomas - a pilot study. Anticancer Res. 2017; 37 (4): 2003–2009. DOI: 10.21873/anticanres.11544.</mixed-citation><mixed-citation xml:lang="en">Liska V., Treska V., Skalicky T., Fichtl J., Bruha J., Vycital O., Topolcan O. , Palek R., Rosendorf J., Polivka J., Holubec L. Evaluation of tumor markers and their impact on prognosis in gallbladder, bile duct and cholangiocellular carcinomas - a pilot study. Anticancer Res. 2017; 37 (4): 2003–2009. DOI: 10.21873/anticanres.11544.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Tomita M., Ayabe T., Chosa E., Nose N., Nakamura K. Prognostic significance of a tumor marker index based on preoperative serum carcinoembryonic antigen and Krebs von den Lungen-6 levels in non-small cell lung cancer. Asian Pac. J. Cancer Prev. 2017; 18 (1): 287–291. DOI: 10.22034/APJCP.2017.18.1.287.</mixed-citation><mixed-citation xml:lang="en">Tomita M., Ayabe T., Chosa E., Nose N., Nakamura K. Prognostic significance of a tumor marker index based on preoperative serum carcinoembryonic antigen and Krebs von den Lungen-6 levels in non-small cell lung cancer. Asian Pac. J. Cancer Prev. 2017; 18 (1): 287–291. DOI: 10.22034/APJCP.2017.18.1.287.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Kim C.G., Ahn J.B., Jung M., Beom S.H., Heo S.J, Kim J.H., Kim Y.J., Kim N.K., Min B.S., Koom W.S., Kim H., Roh Y.H., Ma B.G., Shin S.J. Preoperative serum carcinoembryonic antigen level as a prognostic factor for recurrence and survival after curative resection followed by adjuvant chemotherapy in stage III colon cancer. Ann. Surg. Oncol. 2017; 24 (1): 227–235. DOI: 10.1245/s10434-016-5613-5.</mixed-citation><mixed-citation xml:lang="en">Kim C.G., Ahn J.B., Jung M., Beom S.H., Heo S.J, Kim J.H., Kim Y.J., Kim N.K., Min B.S., Koom W.S., Kim H., Roh Y.H., Ma B.G., Shin S.J. Preoperative serum carcinoembryonic antigen level as a prognostic factor for recurrence and survival after curative resection followed by adjuvant chemotherapy in stage III colon cancer. Ann. Surg. Oncol. 2017; 24 (1): 227–235. DOI: 10.1245/s10434-016-5613-5.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Gangopadhyay A., Lazure D., Thomas P. Adhesion of colorectal carcinoma cells to the endothelium is mediated by cytokines from CEA stimulated Kupffer cells. Clin. Exp. Metastasis. 1998; 16 (8): 703–712. https://www.ncbi.nlm.nih.gov/pubmed/10211983.</mixed-citation><mixed-citation xml:lang="en">Gangopadhyay A., Lazure D., Thomas P. Adhesion of colorectal carcinoma cells to the endothelium is mediated by cytokines from CEA stimulated Kupffer cells. Clin. Exp. Metastasis. 1998; 16 (8): 703–712. https://www.ncbi.nlm.nih.gov/pubmed/10211983.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Семиглазов В.Ф., Айламазян Э.К., Байлюк Е.Н., Ниаури Д.А., Иванов В.Г, Манихас А.Г., Кветной И.М., Сошнев А.А. Профилактика рака молочной железы у больных пролиферативными процессами репродуктивной системы. Вопросы онкологии. 2006; 52 (3): 247–257. http://elibrary.ru/item.asp?id=13003090.</mixed-citation><mixed-citation xml:lang="en">Semiglazov V.F., Ailamazyan E.K., Bailyuk Ye.N., Niauri D.A., Ivanov V.G., Manikhas A.G., Kvetnoi I.M., Soshnev A.A. Prophylaxis of breast cancer in patients with hyperproliferative pathologies of reproductive system. Voprosy onkologii – Problems in Оncology. 2006; 52 (3): 247–257 (in Russ.). http://elibrary.ru/item.asp?id=13003090.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Патологическая анатомия: национальное руководство; под ред. М.А. Пальцева и др. М.: ГЭОТАР-Медиа, 2014: 1264.</mixed-citation><mixed-citation xml:lang="en">Pathologic anatomy: national guidance; рod. red. M.A. Paltseva. М.: GEOTAR-Media Publ., 2014: 1264 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Кунц Т.А., Карпухина К.В., Михайлова Е.С., Варак-син Н.А., Морозов Д.В., Аутеншлюс А.И. Цитокинпродуцирующий потенциал клеток крови при инвазивном протоковом раке и фиброаденоматозе молочной железы. Цитокины и воспаление. 2015; 14 (3): 47–52. http://elibrary.ru/item.asp?id=26511107.</mixed-citation><mixed-citation xml:lang="en">Kunts T.A., Karpukhina K.V., Mikhailova E.S., Varaksin N.A., Morozov D.V., Autenshlyus A.I. Cytokine-producing potential of blood cells in invasive ductal cancer and breast fibroadenoma. Tsitokiny i vospalenie – Cytokines and Inflammation. 2015; 14 (3): 47–52 (in Russ.). http://elibrary.ru/item.asp?id=26511107.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Кунц Т.А., Карпухина К.В., Михайлова Е.С., Вараксин Н.А., Аутеншлюс А.И. Цитокиновый профиль супернатантов иммунокомпетентных клеток периферической крови и опухоли при инвазивном протоковом раке молочной железы. Современные проблемы науки и образования. 2016; 5: 103. https://science-education.ru/ru/article/view?id=25296.</mixed-citation><mixed-citation xml:lang="en">Kunts T.A., Karpukhina K.V., Mikhaylova E.S., Varaksin N.A., Autenshlyus A.I.  Cytokine pattern of supernatant of blood immunocompetent cells and tumor at invasive ductal carcinoma of the breast. Sovremennye problemy nauki i obrasovaniya – Modern Problems of Science and Education. 2016; 5: 103 (in Russ.). https://science-education.ru/ru/article/view?id=25296.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Visscher D.W., Nassar A., Degnim A.C., Frost M.H., Vierkant R.A., Frank R.D., Tarabishy Y., Radisky D.C., Hartmann L.C. Sclerosing adenosis and risk of breast cancer. Breast Cancer Res. Treat. 2014; 144 (1): 205–212. DOI: 10.1007/s10549-014-2862-5.</mixed-citation><mixed-citation xml:lang="en">Visscher D.W., Nassar A., Degnim A.C., Frost M.H., Vierkant R.A., Frank R.D., Tarabishy Y., Radisky D.C., Hartmann L.C. Sclerosing adenosis and risk of breast cancer. Breast Cancer Res. Treat. 2014; 144 (1): 205–212. DOI: 10.1007/s10549-014-2862-5.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Cichon M.A., Degnim A.C., Visscher D.W., Radisky D.C. Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer. J. Mammary Gland Biol. Neoplasia. 2010; 15 (4): 389–397. DOI: 10.1007/s10911-010-9195-8.</mixed-citation><mixed-citation xml:lang="en">Cichon M.A., Degnim A.C., Visscher D.W., Radisky D.C. Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer. J. Mammary Gland Biol. Neoplasia. 2010; 15 (4): 389–397. DOI: 10.1007/s10911-010-9195-8.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
